Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Browse the detailed record of transactions filed by Rosenwald Lindsay A Md, Consejero. Officer active across 5 companies, notably Checkpoint Therapeutics, Inc.. In total, 41 reports have been published. Breakdown: 19 buys · 0 sell. Total volume traded: €6.7m. History available since 10 June 2021. The latest transaction was disclosed on 18 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Rosenwald Lindsay A Md
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
100.000 títulos@ 2,23 US$69.6% de su flujoCommon Stock, par value $0.0001 per shareSEC:0001104659-23-099229:0
Salida canónica: 5 dic 2023 (T+90)
25 de 41 declaraciones
About Rosenwald Lindsay A Md
ROSENWALD LINDSAY A MD is Président, Directeur Général et Administrateur. He has 41 filings in total, and across the sampled recent filings, all transactions are buys for EUR 6683541, with no sales, between 2016-01-05 and 2026-06-26. The recent filings concern Fortress Biotech, Inc., Journey Medical Corp and Avenue Therapeutics, INC., with the transaction nature shown as Attribution.